Taiwan one belt, one road to develop new stem cell drugs

Xuanjie biotechnology company, led by xuanzhi, the honorary vice chairman of liandian, aims at the revolutionary medical innovation in the next 50 years General manager Xuanchang disclosed on the 5th Shanghai Taiwan Forum 2015 jointly organized by Wangbao and the Counselor's office of Shanghai municipal government on March 3 that he is fully developing new stem cell drugs At present, xuanjie has the largest placental stem cell bank in the world, and is preparing to set up a cell production process center to produce products for human body, and is stepping into international human clinical trials Stem cells with regeneration and repair function are the hope of future medical treatment Many rare diseases without medicine are expected to be cured by stem cells In 2009, a girl in Singapore treated cerebral palsy with autologous cord blood stem cells, the first case in Singapore The whole treatment only needs 30 minutes and can be discharged in one day In the future, with the evolution of new stem cell drugs, stem cell drugs can still be used even if cord blood stem cells are not stored at birth Xuanchang, general manager of xuanjie Biotechnology Co., Ltd (photographed by reporter Chen Sihao) Guo Jiayong, Secretary General of the cross strait Biotechnology Industry Development Association (photographed by reporter Chen Sihao) Xuanchang was invited to deliver a keynote speech on Cross Strait biotechnology industry development cooperation at the "2015 5th Shanghai Taiwan Forum" sub forum He said that in 2012, the Nobel Prize in physiology and medicine was awarded to British biologist John Gordon and director of Japan cell research institute Hiroshi Nagayama, which represents that stem cells have been recognized by the world and the era of stem cell industry will come soon With the development and promulgation of regulations, stem cell therapy has been gradually standardized After the first mesenchymal stem cell product was launched in 2011, many products have been launched in accordance with the regulatory process of various countries Guo Jiayong, Secretary General of the Association for promoting the development of cross strait biotechnology industry, pointed out that Jiaotong University established Taiwan's first semiconductor laboratory in 1964, which was transformed by RCA technology in 1976, and then founded by Lianhua electronics, which was founded by alumni of Jiaotong University Jiaotong University is the incubator of Taiwan's semiconductor industry The vision 50 years ago brought Taiwan's leading position in the semiconductor industry for 50 years Guo Jiayong said that in the future, the vision of Jiaotong University turned to bio ICT, which not only actively adjusted the curriculum planning, but also established angel investment club, aiming to establish a leading position in the biomedical industry Xuanjie 's business includes new drug research and development, stem cell storage and prenatal testing Now, xuanjie has established the largest placental and umbilical cord mesenchymal stem cell storage in China At the same time, xuanjie plans to establish a cell production center conforming to the PIC/S GMP standard to produce products that can be used in human body and move towards international human clinical trials Xuanjie integrates the fields of electrical machinery, information, biotechnology and biomedical engineering to analyze the characteristics and cell identification of mesenchymal stem cells Xuan Changyou, a new generation of stem cell repository, said that xuanjie hoped to develop the unique storage and R & D technology, prenatal testing, gene testing and other projects of placental mesenchymal stem cells to the mainland of China to carry out the new generation of stem cell repository on the premise of legality and compliance Meanwhile one belt, one Road Silk Road Economic Belt and the twenty-first Century Maritime Silk Road, which are being promoted by the mainland, are aimed at the infrastructure construction of interconnected infrastructure in Asia.